Dr. Priyal Fadadu is the current first year Complex Family Planning Fellow at the University of Washington. She completed her medical degree and OB/GYN residency training at the Mayo Clinic in Rochester, MN. During her medical training, she completed her Master’s Degree in the Science of Health Care Delivery. Her passion for reproductive health and reproductive justice is exemplified with her advocacy and medical education work. She is also currently a fellow with Physicians for Reproductive Health and is using her research as a tool for advocacy to provide better person-centered care with for those seeking medication abortions.

Dr. Fadadu’s fellowship project is a multi-center prospective study to assess whether completion of medication abortion in very early gestation can be detected within 2 weeks after treatment using remote self-assessment. This study will enroll patients with pregnancies ≤42 days undergoing medication abortion. Participants will take weekly urine pregnancy tests and report pregnancy-related symptoms via weekly questionnaires. The primary objective is to assess the reliability of using a 2-week high-sensitivity pregnancy test as a tool for confirming the success of early medication abortion. Additionally, patients’ self-assessment of abortion completion by monitoring the resolution of pregnancy symptoms will be evaluated. This study will not only help better characterize patient symptomology during early medication abortion, but also could support a patient-centered, remote self-assessment option for early detection of completion of a medication abortion which is very much needed given the changing political landscape in the United States.